Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease-Reference-Cited by-同舟云学术

Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease

Published:2020-12-29 Issue:2 Volume:73 Page:295-304
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Chauvelot Louis¹^ORCID,Gamondes Delphine²,Berthiller Julien³,Nieves Ana⁴,Renard Sébastien⁵,Catella‐Chatron Judith⁶,Ahmad Kais¹,Bertoletti Laurent⁶,Camara Boubou⁷,Gomez Emmanuel⁸,Launay David⁹,Montani David¹⁰,Mornex Jean‐François¹,Prévot Grégoire¹¹,Sanchez Olivier¹²,Schott Anne‐Marie⁴,Subtil Fabien¹³,Traclet Julie¹,Turquier Ségolène¹,Zeghmar Sabrina¹,Habib Gilbert⁵,Reynaud‐Gaubert Martine⁴,Humbert Marc¹⁰,Cottin Vincent¹^ORCID

Affiliation:

1. Hospices Civils de Lyon Centre de Référence National des Maladies Pulmonaires Rares Centre de Compétence de l’Hypertension Pulmonaire Hôpital Louis Pradel UMR 754 Université Claude Bernard Lyon 1, OrphaLung, RespiFil, and ERN‐LUNG Lyon France

2. Hospices Civils de Lyon and Hôpital Louis Pradel Lyon France

3. Hospices Civils de Lyon Université Claude Bernard Lyon 1, and Health Services and Performance Research (HESPER) EA7425 Lyon France

4. Centre de Compétences des Maladies Pulmonaires Rares, and Hôpital Nord AP‐HM Marseille France

5. Hôpital de la Timone AP‐HM Marseille France

6. INSERM U1059 and CHU de Saint‐Etienne Saint‐Etienne France

7. Clinique Universitaire de Pneumologie and CHU de Grenoble Alpes Grenoble France

8. CHRU de Nancy Vandœuvre‐lès‐Nancy France

9. Université de Lille CHU de Lille, and Centre de Référence des Maladies Systémiques et Auto‐Immunes Rares Lille France

10. Hôpital Bicêtre AP‐HP Centre de Référence de l’Hypertension Pulmonaire INSERM U999 Université Paris‐Saclay Paris France

11. Centre de Compétences des Maladies Pulmonaires Rares CHU de Toulouse, and Hôpital Larrey Toulouse France

12. Hôpital Européen Georges Pompidou AP‐HP Centre de Compétences des Maladies Pulmonaires Rares Université Paris Descartes INSERM U1140 Paris France

13. Université de Lyon Université Claude Bernard Lyon 1 CNRS UMR 5558, Villeurbanne, France, and Hospices Civils de Lyon Lyon France

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41512

Reference38 articles.

1. Mapping and predicting mortality from systemic sclerosis

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

3. Updated Clinical Classification of Pulmonary Hypertension

4. Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies

5. Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort;Iudici M;Clin Exp Rheumatol,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients;Medicina;2023-12-28

2. Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension;Respiratory Research;2023-11-07

3. Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension;Expert Opinion on Pharmacotherapy;2023-10-30

4. Clinical features of pulmonary arterial hypertension associated with systemic sclerosis;Frontiers in Medicine;2023-09-27

5. Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension;Respiratory Medicine;2023-09